MARRONCINI, GIADA
 Distribuzione geografica
Continente #
NA - Nord America 592
EU - Europa 389
AS - Asia 153
AF - Africa 1
Totale 1.135
Nazione #
US - Stati Uniti d'America 592
PL - Polonia 100
IT - Italia 93
IE - Irlanda 69
HK - Hong Kong 64
SE - Svezia 52
CN - Cina 31
JO - Giordania 26
SG - Singapore 20
DE - Germania 19
RU - Federazione Russa 18
CH - Svizzera 11
GB - Regno Unito 10
IN - India 6
FI - Finlandia 5
AL - Albania 3
BE - Belgio 2
ES - Italia 2
IL - Israele 2
RO - Romania 2
UA - Ucraina 2
VN - Vietnam 2
FR - Francia 1
JP - Giappone 1
KR - Corea 1
SC - Seychelles 1
Totale 1.135
Città #
Warsaw 100
Fairfield 79
Dublin 69
Chandler 55
Ashburn 50
Hong Kong 50
Seattle 44
Woodbridge 43
Cambridge 35
Houston 33
Altamura 24
Lawrence 24
Wilmington 23
Ann Arbor 19
Bremen 17
Princeton 17
Shanghai 17
Buffalo 15
Singapore 13
Beijing 12
Boston 12
Florence 12
Moscow 12
Bern 11
New York 8
San Diego 8
Boardman 7
Medford 7
Pune 6
West Jordan 6
Villaricca 5
Cagliari 4
Falls Church 4
Norwalk 4
Kent 3
London 3
Tirana 3
Barcelona 2
Brussels 2
Cinisello Balsamo 2
Dong Ket 2
Genoa 2
Los Angeles 2
Padova 2
Piemonte 2
Anaheim 1
Andover 1
Bethesda 1
Cedar Knolls 1
Chiswick 1
Ferrara 1
Fontebuona 1
Frankfurt Am Main 1
Hillsboro 1
Islington 1
La Spezia 1
Lappeenranta 1
Milan 1
Muggiò 1
Naples 1
Perugia 1
Pescara 1
Redwood City 1
Rome 1
San Giovanni Valdarno 1
Seoul 1
Tolentino 1
Washington 1
Totale 893
Nome #
Ambiente e Genetica: due attori nello sviluppo e progressione del danno epatico 169
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells 105
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma 87
A unique neuroendocrine cell model derived from the human foetal neural crest. 86
P0244 : Thieno-triazolodiazepines block hepatocarcinoma progression by HSP-dependent kinoma inhibition 72
Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression 69
Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis 67
Effects of Probiotics Administration on Human Metabolic Phenotype 63
Effects of low extracellular sodium on proliferation and invasive activity of cancer cells in vitro 58
Peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of necrotizing enterocolitis in a neonatal preterm rat model 57
A N-TRUNCATED ISOFORM OF THE ORPHAN NUCLEAR RECEPTOR COUP-TFII MODULATES PANCREATIC CANCER PROGRESSION 51
CHRONIC PARTICULATE MATTER EXPOSITION REPRESENTS A SECOND HIT IN THE PROGRESSION FROM STEATOSIS TO STEATOHEPATITIS 41
Low sodium and tolvaptan have opposite effects in human small cell lung cancer cells 41
THIENO-TRIAZOLODIAZEPINES BLOCK HEPATOCARCINOMA PROGRESSION BY HSP-DEPENDENT KINOMA INHIBITION 33
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 31
Hyponatremia and Cancer: From Bedside to Benchside 26
SIRT1 ACTIVATION PREVENTS APOPTOSIS AND SENESCENCE OF HEPATIC STELLATE CELL DURING LIVER INJURY 25
Hyponatremia-related liver steatofibrosis and impaired spermatogenesis: evidence from a mouse model of the syndrome of inappropriate antidiuresis 24
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS 22
The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells 21
The Yin and Yang Effect of the Apelinergic System in Oxidative Stress 13
Hyponatremia Promotes Cancer Growth in a Murine Xenograft Model of Neuroblastoma 12
Totale 1.173
Categoria #
all - tutte 5.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020204 8 11 5 7 27 23 23 23 33 15 24 5
2020/2021122 11 12 10 17 2 7 7 13 7 17 15 4
2021/2022124 8 6 7 7 3 6 2 16 5 6 19 39
2022/2023357 22 75 21 33 13 57 42 19 41 7 16 11
2023/2024221 4 21 19 6 11 31 12 68 10 17 12 10
2024/202532 32 0 0 0 0 0 0 0 0 0 0 0
Totale 1.173